Abbott Laboratories (ABT)

Total asset turnover

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Revenue (ttm) US$ in thousands 41,950,000 41,217,000 40,725,000 40,326,000 40,109,000 39,959,000 40,226,000 41,505,000 43,653,000 45,030,000 45,548,000 44,514,000 43,075,000 42,308,000 40,233,000 37,338,000 34,608,000 32,221,000 31,444,000 32,095,000
Total assets US$ in thousands 81,414,000 74,356,000 73,017,000 72,467,000 73,214,000 72,090,000 73,354,000 73,794,000 74,438,000 72,801,000 74,202,000 74,007,000 75,196,000 73,795,000 73,269,000 72,785,000 72,548,000 69,043,000 68,793,000 66,712,000
Total asset turnover 0.52 0.55 0.56 0.56 0.55 0.55 0.55 0.56 0.59 0.62 0.61 0.60 0.57 0.57 0.55 0.51 0.48 0.47 0.46 0.48

December 31, 2024 calculation

Total asset turnover = Revenue (ttm) ÷ Total assets
= $41,950,000K ÷ $81,414,000K
= 0.52

The total asset turnover of Abbott Laboratories has shown a general upward trend from 0.48 in March 2020 to 0.52 in December 2024. This indicates that the company has become more efficient in generating sales revenue from its total assets over the period. The highest total asset turnover was recorded in September 2022 at 0.62, suggesting a peak efficiency in asset utilization. However, there was a slight dip in total asset turnover in the most recent quarter ending December 2024, possibly indicating a temporary decrease in asset utilization efficiency. Overall, Abbott Laboratories has demonstrated a gradual improvement in utilizing its total assets to generate sales revenue.


See also:

Abbott Laboratories Total Asset Turnover (Quarterly Data)